Srinivas Katipamula, a staff scientist at PNNL, has been honored with an ASHRAE Exceptional Service Award.

The virus that causes COVID-19 takes over the body’s fat-processing system and boosts cellular triglycerides as it causes disease.

Arun Veeramany furthers the field of risk, reliability, and resilience in civil and mechanical engineering in his new role as an American Society of Civil Engineers-American Society of Mechanical Engineers journal editorial board member.

The Department of Homeland Security Science and Technology Virtual First Responder Capitol Hill Showcase highlighted PNNL work in fentanyl detection standards and database libraries.

Sue Southard's one thousand dives as a PNNL staff member leave a ripple effect on efforts to keep our ocean healthy, our economy thriving, and our waters safe.

PNNL scientists have developed a new mass spectrometry method for in-depth analysis of proteins in individual cells.

The paper was recognized by the Society of Toxicology’s Medical Device and Combination Product Specialty Section.

Proteomics revealed molecular mechanisms by which the drug Verapamil could prolong beta cell function in early-onset type 1 diabetes patients.

Study highlights microbiome’s role in regulating xenobiotic metabolism.

The PNNL-developed Eclipse VOLTTRON™ software platform continues to support new applications in energy efficiency and clean energy.

Development of a one-meter path length miniature ion mobility spectrometer based on multilevel structures for lossless ion manipulations.

Governor Inslee announced the appointment of Karin Rodland to the Board of Directors of the Andy Hill Cancer Research Endowment Fund.

Four research staff from PNNL are part of an international team that earned top honors for a journal paper focused on a new algorithm-evaluation approach for buildings.

The eighth Arab-American Frontiers of Science, Engineering, and Medicine Symposium, co-organized by PNNL engineer and research line manager Leonard Pease, brought together multi-disciplinary researchers from around the globe.

PNNL will provide technical resources and support to a national coalition of states and cities focused on implementing building performance standards to improve energy efficiency and reduce carbon emissions.

Studying MERS-CoV may lead to better treatments for a host of respiratory illnesses, including the many variants of COVID-19.

A study raises questions about how far droplets, like those that carry the virus that causes COVID-19, can travel before becoming harmless.

PNNL scientists are protecting first responders and others by expanding what’s known about fentanyl, the driver of the opioid epidemic.

Researchers characterize protein signatures that indicate Acute Kidney Injury in COVID-19 patients.

Simulations reveal advantages of using new model vs. allometric scaling for risk assessment.